PL2802333T3 - Lactobacillus rhamnosus i Bifidobacterium animalis subsp. lactis do stosowania dla zapobiegania lub leczenia zakażeń górnych dróg oddechowych - Google Patents

Lactobacillus rhamnosus i Bifidobacterium animalis subsp. lactis do stosowania dla zapobiegania lub leczenia zakażeń górnych dróg oddechowych

Info

Publication number
PL2802333T3
PL2802333T3 PL13702584T PL13702584T PL2802333T3 PL 2802333 T3 PL2802333 T3 PL 2802333T3 PL 13702584 T PL13702584 T PL 13702584T PL 13702584 T PL13702584 T PL 13702584T PL 2802333 T3 PL2802333 T3 PL 2802333T3
Authority
PL
Poland
Prior art keywords
lactis
prevention
treatment
respiratory tract
upper respiratory
Prior art date
Application number
PL13702584T
Other languages
English (en)
Inventor
Tracey Jane SMITH
Original Assignee
Chr. Hansen A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47664241&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2802333(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chr. Hansen A/S filed Critical Chr. Hansen A/S
Publication of PL2802333T3 publication Critical patent/PL2802333T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL13702584T 2012-01-13 2013-01-14 Lactobacillus rhamnosus i Bifidobacterium animalis subsp. lactis do stosowania dla zapobiegania lub leczenia zakażeń górnych dróg oddechowych PL2802333T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12151148 2012-01-13
EP13702584.7A EP2802333B1 (en) 2012-01-13 2013-01-14 Lactobacillus rhamnosus and bifidobacterium animalis subsp. lactis for use in prevention or treatment of upper respiratory tract infections
PCT/EP2013/050552 WO2013104783A1 (en) 2012-01-13 2013-01-14 Lactobacillus rhamnosus and bifidobacterium animalis subsp. lactis for use in prevention or treatment of upper respiratory tract infections

Publications (1)

Publication Number Publication Date
PL2802333T3 true PL2802333T3 (pl) 2020-09-07

Family

ID=47664241

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13702584T PL2802333T3 (pl) 2012-01-13 2013-01-14 Lactobacillus rhamnosus i Bifidobacterium animalis subsp. lactis do stosowania dla zapobiegania lub leczenia zakażeń górnych dróg oddechowych

Country Status (8)

Country Link
US (2) US9642883B2 (pl)
EP (1) EP2802333B1 (pl)
CN (1) CN104080465A (pl)
DK (1) DK2802333T3 (pl)
ES (1) ES2795976T3 (pl)
HK (1) HK1198326A1 (pl)
PL (1) PL2802333T3 (pl)
WO (1) WO2013104783A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9642883B2 (en) * 2012-01-13 2017-05-09 Chr. Hansen A/S Lactobacillus rhamnosus and Bifidobacterium animalis subsp. lactis for use in prevention or treatment of upper respiratory tract infections
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
JP6414487B2 (ja) * 2015-02-27 2018-10-31 オムロンヘルスケア株式会社 喘鳴関連情報表示装置
FR3062287B1 (fr) * 2017-01-27 2021-07-16 Denali Pharma Composition probiotique nutritionnelle et utilisation d'une telle composition pour la fabrication d'un supplement de probiotiques
CN107213338A (zh) * 2017-07-19 2017-09-29 颐和益生（北京）科技有限公司 一种具有预防呼吸道感染的抗雾霾组合物、制备方法及应用
WO2020037151A1 (en) 2018-08-16 2020-02-20 Aimmune Therapeutics, Inc. Peanut oral immunotherapy with maintenance dose
JP2022514645A (ja) 2018-12-20 2022-02-14 アイミューン セラピューティクス，インコーポレイテッド ピーナツ経口免疫療法において投与が欠落した場合の投与スケジュール
EP3965815A4 (en) 2019-05-10 2023-05-31 Société des Produits Nestlé S.A. METHOD OF IMPROVING THE QUALITY OF LIFE IN A PEANUT ALLERGY PATIENT
MX2021014348A (es) * 2019-05-28 2022-01-06 Chr Hansen As Proceso para producir un producto lacteo fermentado con un nivel de probioticos aumentado.
CN111154693A (zh) * 2020-01-21 2020-05-15 北京科拓恒通生物技术股份有限公司 一株可改善上呼吸道感染症的鼠李糖乳杆菌Probio-M9及其应用
CN114480229B (zh) * 2022-04-15 2022-08-09 微康益生菌(苏州)股份有限公司 一种动物双歧杆菌乳亚种菌株wkb148及其产品与应用
CN117487700B (zh) * 2023-10-26 2025-11-04 江南大学 一株高产吲哚3甲醛以缓解卵清蛋白引起的呼吸道过敏的动物双歧杆菌乳亚种
WO2025098982A1 (en) * 2023-11-06 2025-05-15 Chr. Hansen A/S Lacticaseibacillus rhamnosus gg and bifidobacterium animalis subsp. lactis for reducing the release of proinflammatory cytokines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
US9642883B2 (en) * 2012-01-13 2017-05-09 Chr. Hansen A/S Lactobacillus rhamnosus and Bifidobacterium animalis subsp. lactis for use in prevention or treatment of upper respiratory tract infections

Also Published As

Publication number Publication date
EP2802333B1 (en) 2020-03-11
US20150118190A1 (en) 2015-04-30
US9642883B2 (en) 2017-05-09
WO2013104783A1 (en) 2013-07-18
US20170258856A1 (en) 2017-09-14
US10286018B2 (en) 2019-05-14
HK1198326A1 (zh) 2015-04-02
CN104080465A (zh) 2014-10-01
EP2802333A1 (en) 2014-11-19
DK2802333T3 (da) 2020-03-23
ES2795976T3 (es) 2020-11-25

Similar Documents

Publication Publication Date Title
PL2802333T3 (pl) Lactobacillus rhamnosus i Bifidobacterium animalis subsp. lactis do stosowania dla zapobiegania lub leczenia zakażeń górnych dróg oddechowych
SMT201800072T1 (it) Ceppo innovativo di bifidobacterium animalis subsp. lactis cect 8145 e relativo uso per il trattamento e/o la prevenzione di peso in eccesso e obesita' e patologie correlate
PL3681470T3 (pl) Lactobacillus casei lub lactobacillus paracasei do stosowania w leczeniu infekcji clostridium difficile
PL3016667T3 (pl) Probiotyczne szczepy bakteryjne do zapobiegania i leczenia chorób w jamie ustnej
IL226212A0 (en) Probiotics are non-replicating microorganisms for protection against inflammation in the upper respiratory tract
ZA201207377B (en) Composition comprising probiotic bacteria for use in the treatment of immune disorders
MX2015007971A (es) Utilizacion de bifidobacterium animalis para el tratamiento o la prevencion de la ganancia de peso corporal y de la resistencia a la insulina.
PL2763685T3 (pl) Bakteria do zastosowania jako probiotyk do zastosowań odżywczych i leczniczych
SG11201404378XA (en) Probiotic derived non-viable material for infection prevention and treatment
PL2364712T3 (pl) Miejscowa kompozycja kosmetyczna lub farmaceutyczna zawierająca probiotyczne szczepy pałeczek bakterii kwasu mlekowego i jej stosowanie
IL222333A0 (en) Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract
PL2457576T3 (pl) Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji
PL2568815T3 (pl) Fermentacja synergistyczna lactobacillus rhamnosus i lactobacillus paracasei podgatunek paracasei
NZ750450A (en) Use of probiotics in the treatment and/or prevention of atopic dermatitis
PL2854826T3 (pl) Lactobacillus reuteri atcc pta 6475 do stosowania dla zapobiegania utracie kości u ssaków
SG11201504542PA (en) Probiotic strains for the treatment and/or prevention of diarrhœa
EP2992765C0 (en) SOYMILK FERMENTED WITH STREPTOCOCCUS THERMOPHILUS AND LACTOBACILLUS BULGARICUS
PL2209527T3 (pl) Kompozycje farmaceutyczne zawierające probiotyki L.acidophilus i Bifidobacterium lactis do stosowania w leczeniu zaburzenia czynnościowego jelit
SMT202300225T1 (it) Preparazione comprendente lactobacillus reuteri e citrato per uso medico
WO2014096083A3 (fr) Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine
ZA201304460B (en) Novel bacterium and extracts of said bacterium and the use of same in therapy
ZA201303631B (en) Detection and/or diagnosis of mite infections in sheep
PL406051A1 (pl) Zastosowanie kompozycji probiotycznej
RS20100436A3 (en) Indigenous LACTOBACILLUS strains and their use as probiotics
PL397178A1 (pl) Kompozycja probiotyczna